✦ LIBER ✦

Gemcitabine, epirubicin and docetaxel as primary systemic therapy in patients with early breast cancer: results of a multicentre phase I/II study

✍ Scribed by A. Schneeweiss; J. Huober; H.-P. Sinn; D. von Fournier; C. Rudlowski; F. Beldermann; K. Krauss; E. Solomayer; R. Hamerla; D. Wallwiener; G. Bastert

Book ID: 116428329
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 269 KB
Volume: 40
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2004.08.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and epirubicin in patients w

Gemcitabine and epirubicin in patients with metastatic breast cancer: A phase I/II study

✍ Mario Campone; Pierre Fumoleau; Patrice Viens; Véronique Diéras; Eric Pujade-Lau 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 188 KB

A Phase II Trial of Neoadjuvant Gemcitab

A Phase II Trial of Neoadjuvant Gemcitabine, Epirubicin, and Docetaxel as Primary Treatment of Patients With Locally Advanced or Inflammatory Breast Cancer

✍ Denise A. Yardley; Nancy W. Peacock; Natalie R. Dickson; Melissa B. White; Eliza 📂 Article 📅 2010 🏛 CIG Media Group, LP. 🌐 English ⚖ 609 KB

The triplet gemcitabine (G), epirubicin

The triplet gemcitabine (G), epirubicin (E) and docetaxel (Doc) is feasible, safe and highly active as primary systemic therapy (PST) of patients (pts) with multicentric phase I/II trial

✍ A. Schneeweiss; M. Geberth; K. Krauss; F. Beldermann; U. Wagner; D. von Fournier 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 192 KB

Epirubicin plus cyclophosphamide vs. wee

Epirubicin plus cyclophosphamide vs. weekly paclitaxel as primary systemic therapy in patients with stage II and III breast cancer: randomized phase II study

✍ M. Miyashita; Kohno; S. Takao; K. Wakita; M. Konishi; H. Yoshimura; M. Kubota; Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 136 KB

A Multicentre Phase II Pilot Study of Ep

A Multicentre Phase II Pilot Study of Epirubicin and Taxol™ (Paclitaxel) in Patients with Advanced Breast Cancer

✍ J. White; A. Howells; A. Jones; C. Poole; M. Lind; N. Stuart; J. Carmichael 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Biweekly docetaxel and gemcitabine as ne

Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy in stage II and III breast cancer patients: Preliminary results of a phase II and pharmacogenomic study

✍ Laura G Estévez; Pedro Sánchez-Rovira; Manuel Dómine; A León; Isabel Calvo; Ana 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 89 KB